MODERATE TO SEVERE ATOPIC DERMATITIS
Clinical trials for MODERATE TO SEVERE ATOPIC DERMATITIS explained in plain language.
Never miss a new study
Get alerted when new MODERATE TO SEVERE ATOPIC DERMATITIS trials appear
Sign up with your email to follow new studies for MODERATE TO SEVERE ATOPIC DERMATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection shows promise for severe eczema relief in major trial
Disease control OngoingThis large Phase 3 study is testing whether an injectable medication called SHR-1819 can safely reduce symptoms in adults with moderate to severe atopic dermatitis (eczema). Researchers are comparing the drug against a placebo in 652 participants to see if it significantly improv…
Matched conditions: MODERATE TO SEVERE ATOPIC DERMATITIS
Phase: PHASE3 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New injection shows promise for controlling severe eczema
Disease control OngoingThis study is testing whether an investigational drug called rezpegaldesleukin can help control moderate-to-severe eczema (atopic dermatitis) in adults. About 400 participants will receive either the drug or a placebo injection to compare effectiveness. The main goal is to see ho…
Matched conditions: MODERATE TO SEVERE ATOPIC DERMATITIS
Phase: PHASE2 • Sponsor: Nektar Therapeutics • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC